Gainers
- Jaguar Health JAGX shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $95.6 million.
- Avenue Therapeutics ATXI shares moved upwards by 13.49% to $1.43. The current volume of 240.9K shares is 388.15% of Avenue Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $24.0 million.
- Progenity PROG stock rose 13.34% to $3.35. Progenity's stock is trading at a volume of 92.2 million shares as of 12:30 EST. This is 194.37% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $445.3 million.
- Xeris Biopharma Holdings XERS shares increased by 12.36% to $2.04. As of 12:30 EST, Xeris Biopharma Holdings's stock is trading at a volume of 4.1 million, which is 125.54% of its average full-day volume over the last 100 days. The company's market cap stands at $256.2 million.
- Evaxion Biotech EVAX stock rose 11.11% to $8.6. The company's market cap stands at $165.1 million.
- Kiromic BioPharma KRBP stock moved upwards by 10.41% to $2.12. As of 12:30 EST, Kiromic BioPharma's stock is trading at a volume of 10.7 million, which is 4373.48% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $32.7 million.
Losers
- Erytech Pharma ERYP shares fell 39.33% to $3.33 during Monday's regular session. Trading volume for this security as of 12:30 EST is 865.8K, which is 80.32% of its average full-day volume over the last 100 days. The company's market cap stands at $92.8 million.
- Eyenovia EYEN stock declined by 37.09% to $4.14. Trading volume for this security as of 12:30 EST is 3.0 million, which is 1333.42% of its average full-day volume over the last 100 days. The company's market cap stands at $107.4 million.
- Esperion Therapeutics ESPR stock declined by 10.98% to $7.83. The current volume of 1.2 million shares is 154.26% of Esperion Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $221.2 million.
- Statera BioPharma STAB stock fell 10.4% to $3.19. The market value of their outstanding shares is at $88.2 million.
- Revance Therapeutics RVNC shares declined by 9.85% to $13.92. As of 12:30 EST, this security is trading at a volume of 898.4K shares, making up 94.72% of its average full-day volume over the last 100 days. The company's market cap stands at $999.8 million.
- INmune Bio INMB shares declined by 8.17% to $18.33. Trading volume for INmune Bio's stock is 118.3K as of 12:30 EST. This is 26.48% of its average full-day volume over the last 100 days. The company's market cap stands at $327.0 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
ATXIAvenue Therapeutics Inc
$0.2600-38.1%
Edge Rankings
Momentum
N/A
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
